Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

Abroad (travel likely)RecruitingPHASE4

Conditions

Crohn's Disease and Ulcerative Colitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Jiayin Yao, Professor) · yjyin@mail2.sysu.edu.cn · +86 13826462890

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Winnipeg, Canada

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Inflammatory Bowel Disease · Colitis, Ulcerative · Crohn's Disease

Abroad (travel likely)Recruiting

Harrow, United Kingdom

Immunological Characteristics of Preclinical IBD

Crohn Disease · Ulcerative Colitis · IBD

Abroad (travel likely)Recruiting

Santiago de Compostela, Spain · Badalona, Spain

Nutrition and Clinical Outcomes in IBD

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)Recruiting

London, United Kingdom